The relationship between poly ADP-ribose polymerase-1 gene expression and protein kinase β expression with neoadjuvant chemotherapy response in triple negative breast cancer subtype

Read full text Summarise with VIRAT
Authors: I Wayan Gede Suarsana, Amirul Islam
Cited by: 0
References: 34

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Introduction: Breast cancer is the most common and deadliest cancer among women worldwide. One of its subtypes with a particularly poor prognosis is triple‐negative breast cancer (TNBC). Patients with TNBC often receive various therapeutic approaches, including neoadjuvant chemotherapy. However, the wide genetic heterogeneity of TNBC results in highly variable responses to chemotherapy. Poly(ADP-ribose) polymerase-1 (PARP1) expression, a defense mechanism against chemotherapy, and Protein Kinase β (AKT) activation, which increases tumor aggressiveness, are thought to influence chemotherapy responses in these patients.

Fields of Study & Subjects

Breast Cancer Treatment Studies PARP inhibition in cancer therapy Breast Lesions and Carcinomas

Publication details

Journal / source
Gaceta Médica de Caracas
Volume
134
Issue
1
Pages
22–35
Publication date
20 March 2026
Language
EN